Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-20

Clinical Trial Update: Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis [Phase 2]

View source ↗

Summary

Phase II study evaluating sarilumab for non-infectious uveitis has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarilumab (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Uveitis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-20